PEGS Virtual Interactive Global Summit

Co-founder and Head of Business Development, Kevin Heyries, Ph.D. will be presenting “From Patient Screen to Phase I in 90 Days: Identifying Neutralizing Antibodies for the World’s First Study of a Potential COVID-19 Antibody Treatment”, in the Making Antibodies Rapidly to Combat Pandemic Viruses session on Tuesday, June 23, 2020.